Esophageal Neoplasms
168
27
28
70
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
15 trials with published results (9%)
Research Maturity
70 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.1%
22 terminated out of 168 trials
76.1%
-10.4% vs benchmark
11%
19 trials in Phase 3/4
21%
15 of 70 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 70 completed trials
Clinical Trials (168)
Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM)
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery
Mayo Clinic Upper Digestive Disease Survey
Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer
PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer
Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer
Esophageal Cancer Multimodal Prehabilitation Study
Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI
Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer
Endoscopic Resection of Gastrointestinal Neoplasms
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab
Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
HTL0039732 in Participants With Advanced Solid Tumours
Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy
Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus.